bioRxiv
Convergent evolution of p38/MAPK activation in hormone resistant prostate cancer mediates pro-survival, immune evasive, and metastatic phenotypes
Publication
, Preprint
Ware, K; Gupta, S; Eng, J; Kemeny, G; Puviindran, B; Foo, W-C; Crawford, L; Garland Almquist, R; Runyambo, D; Thomas, B; Sheth, M; Agarwal, A ...
2020
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Citation
APA
Chicago
ICMJE
MLA
NLM
Ware, K., Gupta, S., Eng, J., Kemeny, G., Puviindran, B., Foo, W.-C., … Somarelli, J. (2020). Convergent evolution of p38/MAPK activation in hormone resistant prostate cancer mediates pro-survival, immune evasive, and metastatic phenotypes. bioRxiv. https://doi.org/10.1101/2020.04.22.050385
Ware, Kathryn, Santosh Gupta, Jared Eng, Gabor Kemeny, Bhairavy Puviindran, Wen-Chi Foo, Lorin Crawford, et al. “Convergent evolution of p38/MAPK activation in hormone resistant prostate cancer mediates pro-survival, immune evasive, and metastatic phenotypes.” BioRxiv, 2020. https://doi.org/10.1101/2020.04.22.050385.
Ware K, Gupta S, Eng J, Kemeny G, Puviindran B, Foo W-C, et al. Convergent evolution of p38/MAPK activation in hormone resistant prostate cancer mediates pro-survival, immune evasive, and metastatic phenotypes. bioRxiv. 2020.
Ware, Kathryn, et al. “Convergent evolution of p38/MAPK activation in hormone resistant prostate cancer mediates pro-survival, immune evasive, and metastatic phenotypes.” BioRxiv, 2020. Epmc, doi:10.1101/2020.04.22.050385.
Ware K, Gupta S, Eng J, Kemeny G, Puviindran B, Foo W-C, Crawford L, Garland Almquist R, Runyambo D, Thomas B, Sheth M, Agarwal A, Pierobon M, Petricoin E, Corcoran D, Freedman J, Patierno S, Zhang T, Gregory S, Sychev Z, Drake J, Armstrong A, Somarelli J. Convergent evolution of p38/MAPK activation in hormone resistant prostate cancer mediates pro-survival, immune evasive, and metastatic phenotypes. bioRxiv. 2020.